Marietta Wu

Dr. Wu is Managing Director of Quan Capital, a life sciences venture fund with offices in China and the US. She is a founding member of Zai Lab (NASDAQ: ZLAB) and served as Chief Operating Officer and Director of the company prior to Quan Capital. Over the past decade, Dr. Wu has been active in cross-border ventures and value creation in the life sciences industry. Dr. Wu is also a frequent speaker and an author on China and Taiwan life sciences topics, and a founding member of the China Healthcare Investment Conference.

Dr. Wu received her medical degree from Shanghai Jiaotong University School of Medicine (formerly Shanghai Second Medical University), a Ph.D. in Medical Sciences from Medical College of Ohio, and an MBA from the University of Michigan Ross School of Business. Dr. Wu serves on the board of Citrine, Crescendo Biologics, Innoforce, Kira Pharmaceutical, MEDx Translational Medicine and Zidan Medical.